SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
HHHHHJ
Lv1
1
8 积分
2023-12-11 加入
最近求助
最近应助
互助留言
Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation
1小时前
已完结
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma
1天前
已完结
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
1天前
已完结
Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma
2天前
已完结
Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
2天前
已完结
Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis
3天前
已完结
Sequencing of systemic therapy in unresectable hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis of randomized clinical trials
3天前
已完结
Efficacy of systemic therapy for advanced hepatocellular carcinoma based on etiology: A systematic review and network meta-analysis of randomized phase III trials
16天前
已关闭
Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis
16天前
已完结
Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status
19天前
已完结
没有进行任何应助
速度真快,帮大忙了
24天前
速度真快,感谢
1个月前
感谢
3个月前
感谢
5个月前
感谢,速度真快,帮大忙了
5个月前
感谢
6个月前
文献已找到【积分已退回】
7个月前
感谢
8个月前
感谢,点赞,速度真快,帮大忙了,么么哒
9个月前
朋友,感谢您的上传!祝您天天开心:)
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论